Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 July, 2017 20:26 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
ICRA upgrades credit rating of Dwarikesh Sugar's Rs 5.99 bn line of credit - 21-Jul-2017 15:51
Dewan Housing Finance Corporation quarterly profit up 29% - 21-Jul-2017 13:40
Ashok Leyland quarterly earnings plunge 62% - 21-Jul-2017 13:34
USFDA completes audit at Dr. Reddy's API Cuernavaca plant in Mexico - 21-Jul-2017 12:06
Suven Life Sciences secures one product patent in Australia - 21-Jul-2017 12:03
Reliance Nippon Life records 8% premium growth in Q1FY18 - 21-Jul-2017 10:49
Welspun Corp bags order for supply of 100K MTs pipes - 21-Jul-2017 09:57
Gravita India's arm commences commercial production at new plant at Jamaica - 21-Jul-2017 09:53
Reliance to acquire 24.92% stake in Balaji Telefilms for Rs 4.13 bn - 21-Jul-2017 09:48
Reliance to acquire 24.92% stake in Balaji Telefilms for Rs 4.13 bn - 21-Jul-2017 09:48
Bajaj Auto quarterly net drops 5.6% - 21-Jul-2017 09:42
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer